⌘K

Home/Filings/4/0001213900-20-027389

4//SEC Filing

Navon Nadav 4

Accession 0001213900-20-027389

CIK 0001638381other

View on SEC.gov Company Profile

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 5:00 PM ET

Size

5.2 KB

Accession

0001213900-20-027389

Insider Transaction Report

Form 4

Period: 2020-09-16

Intec Pharma Ltd.NTEC

Chief Operating Officer

Transactions

Award
Stock Option (right to buy)
2020-09-16+100,000→ 100,000 total
Exercise: $0.32Exp: 2027-09-16→ Ordinary Shares (100,000 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable in full on December 31, 2021.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Intec Pharma Ltd.

CIK 0001638381

Entity typeother

Related Parties

1

filerCIK 0001760979

Filing Metadata

Form type: 4
Filed: Sep 17, 8:00 PM ET
Accepted: Sep 18, 5:00 PM ET
Size: 5.2 KB

View on SEC.gov